High-grade serous epithelial ovarian cancer, BRCA negative, in two 18-year-old women: case report

被引：0
|
作者：
Cortes-Esteban, Patricia [1 ]
Gomez-Avalos, Julieta [2 ]
Millan-Aguilar, Hugo [3 ]
Adame-Gonzalez, Ignacio [4 ]
Jasso-Sosa, Velma [5 ]
机构：
[1] ISSSTE, Dept Oncol Med, Ctr Med Nacl Noviembre 20, Clin Tumores Ginecol, Mexico City, Mexico
[2] ISSSTE, Dept Oncol Med, Ctr Med Nacl Noviembre 20, Mexico City, Mexico
[3] Fdn Canc Mama, Dept Oncol Med, Mexico City, Mexico
[4] ISSSTE, Dept Med Nucl, Ctr Med Nacl Noviembre 20, Mexico City, Mexico
[5] ISSSTE, Dept Anat Patol, Ctr Med Nacl Noviembre 20, Mexico City, Mexico
来源：
GACETA MEXICANA DE ONCOLOGIA | 2023年 / 22卷
关键词：
Ovarian cancer; BRCA; PARP inhibitor; BEVACIZUMAB;
D O I：
10.24875/j.gamo.220000951
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Two previously healthy 18-year-old Mexican women referred for medical evaluation due to ascites. Clinical studies revealed the presence of ovarian-dependent tumors, and elevated CA-125. A diagnostic laparotomy was performed, with a pathology report of a high-grade papillary serous adenocarcinoma. BRCA 1 and 2 was performed and reported negative for both patients. Chemotherapy and antiangiogenic treatment were started. One of the patients was considered a candidate for a poly (ADP-ribose) polymerase inhibitor.
引用
收藏
页码：41 / 46
页数：6
相关论文
共 50 条
  • [41] Spectrum of TP53 Mutations in BRCA1/2 Associated High-Grade Serous Ovarian Cancer
    Boyarskikh, Ulyana A.
    Gulyaeva, L. F.
    Avdalyan, A. M.
    Kechin, A. A.
    Khrapov, E. A.
    Lazareva, D. G.
    Kushlinskii, N. E.
    Melkonyan, A.
    Arakelyan, A.
    Filipenko, Maxim Leonidovich
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [42] Proteomic signature for detection of high-grade ovarian cancer in germline BRCA mutation carriers
    Bahar-Shany, Keren
    Barnabas, Georgina D.
    Deutsch, Lisa
    Deutsch, Netanel
    Glick-Saar, Efrat
    Dominissini, Dan
    Sapoznik, Stav
    Helpman, Limor
    Perri, Tamar
    Blecher, Anna
    Katz, Guy
    Yagel, Itai
    Rosenblatt, Orgad
    Shai, Daniel
    Brandt, Benny
    Meyer, Raanan
    Mohr-Sasson, Aya
    Volodarsky-Perel, Alexander
    Zilberman, Itamar
    Armon, Shunit
    Jakobson-Setton, Ariella
    Eitan, Ram
    Kadan, Yfat
    Beiner, Mario
    Josephy, Dana
    Brodsky, Malka
    Friedman, Eitan
    Anafi, Liat
    Molchanov, Yossef
    Korach, Jacob
    Geiger, Tamar
    Levanon, Keren
    INTERNATIONAL JOURNAL OF CANCER, 2023, 152 (04) : 781 - 793
  • [43] Comparison of Survival Outcomes According to BRCA1/2 Variant Type in High-grade Serous Ovarian Cancer
    Lee, Juhun
    Kim, Jong Mi
    Lee, Yoon Hee
    Chong, Gun Oh
    Lee, Nan Young
    Lee, In Hee
    Park, Ji Young
    Hong, Dae Gy
    IN VIVO, 2022, 36 (04): : 1903 - 1910
  • [44] The Effect of WT-1 Positivity on Survival Outcomes in Patients with High-grade Serous Epithelial Ovarian Cancer
    Karakas, Sema
    Tunca, Aysun Fendal
    Altinay, Serdar
    Yildiz, Gunes Ozlem
    Ekin, Murat
    MEDICAL JOURNAL OF BAKIRKOY, 2022, 18 (02) : 151 - 156
  • [45] The role of GATA3 in the metastasis of triple-negative breast cancer and high-grade serous ovarian cancer
    Amr Ahmed El-Arabey
    Mohnad Abdalla
    Human Cell, 2022, 35 : 1298 - 1300
  • [46] Referral, Genetic Counselling, and BRCA Testing in the Manitoba High-Grade Serous Ovarian Cancer Population, 2004-2019
    Winchar, Kelcey
    Lambert, Pascal
    McManus, Kirk J.
    Chodirker, Bernie
    Kean, Sarah
    Serfas, Kim
    Decker, Kathleen
    Nachtigal, Mark W.
    Altman, Alon D.
    CURRENT ONCOLOGY, 2022, 29 (12) : 9365 - 9376
  • [47] The role of GATA3 in the metastasis of triple-negative breast cancer and high-grade serous ovarian cancer
    El-Arabey, Amr Ahmed
    Abdalla, Mohnad
    HUMAN CELL, 2022, 35 (04) : 1298 - 1300
  • [48] The performance of BRCA1 immunohistochemistry for detecting germline, somatic, and epigenetic BRCA1 loss in high-grade serous ovarian cancer
    Meisel, J. L.
    Hyman, D. M.
    Garg, K.
    Zhou, Q.
    Dao, F.
    Bisogna, M.
    Gao, J.
    Schultz, N. D.
    Grisham, R. N.
    Phillips, M.
    Iasonos, A.
    Kauff, N. D.
    Levine, D. A.
    Soslow, R. A.
    Spriggs, D. R.
    ANNALS OF ONCOLOGY, 2014, 25 (12) : 2372 - +
  • [49] Reflex BRCA1 and BRCA2 tumour genetic testing for high-grade serous ovarian cancer: streamlined for clinicians but what do patients think?
    McCuaig, Jeanna M.
    Ferguson, Sarah E.
    Vicus, Danielle
    Ott, Karen
    Stockley, Tracy L.
    Kim, Raymond H.
    Metcalfe, Kelly A.
    HEREDITARY CANCER IN CLINICAL PRACTICE, 2022, 20 (01)
  • [50] First-line medical treatment of high-grade epithelial ovarian cancer
    Selle, Frederic
    Alexandre, Jerome
    Prulhiere, Karine
    Kalbacher, Elsa
    Ray-Coquard, Isabelle
    Leary, Alexandra
    BULLETIN DU CANCER, 2021, 108 (09) : S5 - S12
12345